mii-exa-medikation-medication-administration - MII IG Medikation v2027.0.0-ballot

MII IG Medikation
2027.0.0-ballot - Germany

This page is part of the MII Implementation Guide MII IG Medikation (v2027.0.0-ballot: 2027 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Beispiel MedicationAdministration: mii-exa-medikation-medication-administration

German

Profile: MII PR Medikation MedicationAdministration version: 2027.0.0-ballot

Security Label: test health data (Details: ActReason code HTEST = 'test health data')

status: Completed

medication: Medication

subject: Max Mustermann Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)

effective: 2020-01-06 10:20:00+0000 --> 2020-01-06 11:20:00+0000

Dosages

Route

Dose

Rate[x]

Intravenous use

85 mg (Details: UCUM codemg = 'mg')

250 milliliter (Details: UCUM codemL = 'mL')/1 hour (Details: UCUM codeh = 'h')

IG © 2019+ NUM-DIZ. Package de.medizininformatikinitiative.kerndatensatz.medikation#2027.0.0-ballot basiert auf FHIR 4.0.1. Erstellt 2026-09-11
Links: Inhaltsverzeichnis | QA-Bericht | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Impressum
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.